P. Bakakos (Athens, Greece), M. Bafadhel (London, United Kingdom)
Introduction
P. Bakakos (Athens, Greece), M. Bafadhel (London, United Kingdom)
|  |
The Upper and Lower Airway Microbiome in Severe Asthma
M. Jabeen (Oxford, United Kingdom), N. Sanderson (Oxford, United Kingdom), C. Barber (Southampton, United Kingdom), L. Lau (Southampton, United Kingdom), I. Pavord (Oxford, United Kingdom), A. Chauhan (Portsmouth, United Kingdom), P. Klenerman (Oxford, United Kingdom), T. Street (Oxford, United Kingdom), P. Howarth (Southampton, United Kingdom), T. Hinks (Oxford, United Kingdom)
|    |
Comparison of the influence of omalizumab and mepolizumab on airway remodeling in severe asthma patients with evaluation of detection techniques: endobronchial ultrasound (EBUS) and high-resolution computed tomography (HRCT)
M. Przybyszowski (Kraków, Poland), W. Zastrzezynska (Kraków, Poland), A. Gawlewicz-Mroczka (Kraków, Poland), I. Gross-Sondej (Kraków, Poland), J. Zarychta (Zakopane, Poland), S. Bazan-Socha (Kraków, Poland), G. Bochenek (Kraków, Poland), J. Soja (Kraków, Poland), K. Sladek (Kraków, Poland)
| |
Radiomics for severe asthma phenotyping and endotyping
N. Zounemat Kermani (London, United Kingdom), G. Macis (Roma, Italy), P. Bakke (Bergen, Norway), M. Caruso (Catania, Italy), P. Chanez (Masrseille, France), R. Djukanovic (Southampton, United Kingdom), S. Fowler (Manchester, United Kingdom), Y. Guo (London, United Kingdom), I. Horvath (Budapest, Hungary), P. Howarth (Southampton, United Kingdom), A. Maitland-Van Der Zee (Amsterdam, Netherlands), M. Malerba (Novara, Italy), G. Roberts (Southampton, United Kingdom), M. Sanak (Krakow, Poland), D. Shaw (Nottingham, United Kingdom), S. Wilson (Southampton, United Kingdom), S. Siddiqui (London, United Kingdom), S. Dahlen (Stockholm, Sweden), K. Chung (London, United Kingdom), I. Adcock (London, United Kingdom), P. Montuschi (Roma, Italy), ,. On Behalf Of The U-Biopred Study Group (Roma, Italy)
| |
Risk factors for corticosteroid- and antibiotic only-treated asthma attacks in the NOVELTY cohort
S. Couillard (Sherbrooke, QC, Canada), S. Peterson (Lund, Sweden), T. Bengtsson (Lund, Sweden), M. Van Den Berge (Groningen, Netherlands), D. Price (Singapore, Singapore), R. Beasley (Wellington, New Zealand), M. Sadatsafavi (Vancouver, BC, Canada), C. Janson (Uppsala, Sweden), A. Papi (Ferrara, Italy), L. Belton (Cambridge, United Kingdom), M. Fagerås (Gothenburg, Sweden), H. Müllerová (Cambridge, United Kingdom), I. Pavord (Oxford, United Kingdom)
| |
A primary ciliary dysfunction might be present in severe asthma
C. Kempeneers (Liège, Belgium), R. Bonhiver (Liège, Belgium), N. Bricmont (Liège, Belgium), M. Pirotte (Liège, Belgium), F. Guissard (Liège, Belgium), C. Moermans (Liège, Belgium), M. Seghaye (Liège, Belgium), R. Louis (Liège, Belgium), F. Schleich (Liège, Belgium)
| |
Alterations of humoral immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease
A. Di Stefano (Veruno (NO), Italy), F. Dossena (Veruno (NO), Italy), I. Gnemmi (Veruno (NO), Italy), V. Carriero (Torino, Italy), F. Bertolini (Torino, Italy), F. Nucera (Messina, Italy), S. D'Anna (Telese, Italy), M. Maniscalco (Telese, Italy), P. Brun (Padova, Italy), A. Piraino (Parma, Italy), A. Spanevello (Tradate, Italy), B. Balbi (Veruno, Italy), G. Caramori (Messina, Italy), F. Ricciardolo (Torino, Italy)
| |
Influence of parental disease phenotypes and smoking on fractional exhaled nitric oxide values in offspring
S. Zaigham (Malmö, Sweden), R. Bertelsen (Bergen, Norway), S. Dharmage (Melbourne, Australia), V. Schlünssen (Aarhus, Denmark), N. Jögi (Bergen, Norway), L. Palacios-Gomez (Huelva, Spain), M. Holm (Gothenburg, Sweden), A. Oudin (Umeå, Sweden), M. Abramson (Melbourne, Australia), T. Sigsgaard (Aarhus, Denmark), R. Jõgi (Tartu, Estonia), C. Svanes (Bergen, Norway), A. Olin (Gothenberg, Sweden), B. Forsberg (Umeå, Sweden), C. Janson (Uppsala, Sweden), E. Nerpin (Uppsala, Sweden), A. Johannessen (Bergen, Norway), A. Malinovschi (Uppsala, Sweden)
| |
Neither baseline blood nor sputum eosinophils predict future exacerbations in the SPIROMICS cohort
A. Hastie (Winston-Salem, United States), P. Quibrera (Chapel Hill, United States), D. Couper (Chapel Hill, United States), N. Alexis (Chapel Hill, United States), I. Barjaktarevic (Los Angeles, United States), J. Curtis (Ann Arbor, United States), E. Bleecker (Tucson, United States)
| |
Stability of sputum eosinophil cell counts in COPD
A. Beech (Manchester, United Kingdom), N. Jackson (Manchester, United Kingdom), D. Singh (Manchester, United Kingdom)
| |
Late Breaking Abstract - Clinical predictors and phenotypic associations of mucus plugging in moderate to severe asthma
R. Chan (Dundee, United Kingdom), C. Duraikannu (Dundee, United Kingdom), B. Lipworth (Dundee, United Kingdom)
| |